Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedThe page's revision line was updated from v3.6.3 to v3.6.4, reflecting a new site version.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page no longer shows the condition label 'Multiple myeloma' and removes the 'MedlinePlus Genetics' related topics section. This reduces explicit health-topic labeling and the available related-resource links on the study page, affecting how users interpret the study focus and find background information.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the page, signaling a page update. This change does not modify the study content or details presented.SummaryDifference0.1%

- Check32 days agoChange DetectedThe page now includes a 'Multiple myeloma' entry and related topics such as MedlinePlus Genetics, and the site revision label updates from v3.6.0 to v3.6.2.SummaryDifference0.2%

- Check46 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants', indicating enrollment for the study is closed. The page also adds or updates navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0.SummaryDifference0.6%

- Check54 days agoChange DetectedMultiple myeloma was added as a condition and MedlinePlus Genetics was added as a related topic. The revision tag was updated from v3.5.4 to v3.5.5.SummaryDifference0.2%

Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.